# A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

> **NCT07207707** · PHASE1 · RECRUITING · sponsor: **Kumquat Biosciences Inc.** · enrollment: 78 (estimated)

## Conditions studied

- Solid Tumor Malignancies

## Interventions

- **DRUG:** KQB548

## Key facts

- **NCT ID:** NCT07207707
- **Lead sponsor:** Kumquat Biosciences Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-16
- **Primary completion:** 2026-09
- **Final completion:** 2027-03
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07207707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07207707, "A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07207707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*